ESAB-SKB Webinar on Biocatalysis and Molecular Medicine


ESAB-SKB Webinar

Biocatalysis and Molecular Medicine

Friday, 29th  July 2022

09:00-11:00 British Summer Time (BST)          
10:00-12:00 Central European Time (CET)
16.00-18.00 China Standard Time (CST)

17.00-19.00 Japan Standard Time (JST)
 

Chairs

  • Jennifer Littlechild (University of Exeter)
  • Roland Wohlgemuth (Lodz University of Technology)
  • Antonio Ballesteros (CSIC, Madrid)
  • Thomas Sauter (Université du Luxembourg)
     

Programme / Speakers (25 min. lecture, 5 min. discussion)

10:00 - 10:30 CEST Critical mechanisms in the pathogenesis of persistent bacterial infections

Prof. Dr. Thomas F. Meyer
Max Planck Institute for Infection Biology, Department of Molecular Biology, Berlin, and Laboratory of Infection Oncology, Institute of Clinical Molecular Biology, Christian Albrecht’s University of Kiel and University Hospital Schleswig Holstein – Campus Kiel, Germany

10:30 - 11:00 CEST
Mucopolysaccharidoses - molecular mechanisms and treatment options of disorders caused by defects in biocatalysis of  glycosaminoglycan decay 

Prof. Dr. Grzegorz Wegrzyn
Department of Molecular Biology, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland

11:00 - 11:30 CEST Biocatalysis in Cells through Proteolysis Targeting Chimeras (PROTACs): How to Improve Cell Permeability and Achieve Successful Protein Degradation

Prof. Dr. Leonardo Scapozza
School of Pharmaceutical Sciences, and Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Switzerland

11:30 - 12:00 CEST The use of systems biology in treatment of liver diseases

Prof. Dr. Adil Mardinoglu
Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden, and Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King’s College London, London, United Kingdom

Flyer
Abstracts and Short Bios of the speakers

 


Latest from E-Congress 2024
ESAB E-CONGRESS 2024


Under the Spotlight
Latest news